PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - April 25, 2016) - MolecularMD Corp., a molecular diagnostics company that accelerates oncology drug development by providing custom companion diagnostic ...

PORTLAND, OR--(Marketwired - Feb 19, 2014) - MolecularMD Corp. today announced that it has entered into a collaboration with Novartis Pharmaceuticals Corporation to develop a companion diagnostic test ...

PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Jun 12, 2014) - MolecularMD Corp., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial ...

FRANKLIN LAKES, N.J. and PORTLAND, Ore., June 2, 2011 /PRNewswire/ -- Medco Health Solutions, Inc. (NYSE: MHS) and MolecularMD Corp. today announce the launch of a personalized medicine program for ...

Ballast Point Ventures, a St. Petersburg, Fla., firm affiliated with Raymond James Financial, Inc. closed a $3 million growth equity investment in MolecularMD Corporation, a West Palm Beach, Fla., ...

Personal Genome Diagnostics (PGDx) is teaming up with MolecularMD to market a suite of personalized medicine services to cancer researchers and drug developers. The collaboration is designed to ...

PORTLAND, Ore. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- MolecularMD Corp. and ARIAD Pharmaceuticals, Inc. (NAS: ARIA) today announced that MolecularMD has voluntarily withdrawn its Premarketing Approval ...

Personal Genome Diagnostics Inc. (PGDx), a company committed to bringing genomic innovation to cancer research and clinical care, to collaborate with MolecularMD to market a suite of comprehensive ...

PORTLAND, Ore. and CAMBRIDGE, Mass., Sept. 28, 2017 (GLOBE NEWSWIRE) -- MolecularMD, a provider of molecular and tissue-based clinical trial assays and diagnostics for oncology based drug development ...

PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - June 01, 2017) - MolecularMD Corp., a molecular diagnostics company that provides clinical trial services and development of companion diagnostics for ...

(MENAFN- GlobeNewsWire - Nasdaq) itemprop="articleBody">PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that ...